MedTrace Logo

Glasses for Adolescent Delayed Sleep-Wake Phase Disorder

NCT04378933 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-05-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST) and an advance in sleep onset times (shift earlier) compared to the control group.

Conditions

  • Delayed Sleep-Wake Phase Disorder

Interventions

DEVICE

Amber Glasses

Half of the participants will be wearing the amber glasses to see if they can help with sleep onset.

DEVICE

Clear Lens Glasses

Half of the participants will be wearing the clear glasses to see if the glasses help with sleep onset.

Sponsors & Collaborators

Principal Investigators

  • R. Robert Auger, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-27
Primary Completion
2022-06-03
Completion
2022-06-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04378933 on ClinicalTrials.gov